Multiples measured against the stock's own five-year history
Around its usual level · 41st percentile, 5-year average 44.5x
#2188 of 2973 stocks by PE (1 = cheapest)
Around its usual level · 46th percentile, 5-year average 3.2x
#3753 of 5317 stocks by PB (1 = cheapest)
Around its usual level · 54th percentile, 5-year average 1.3x
#1856 of 5146 stocks by PS (1 = cheapest)
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 3.18 | – | 3.23 | 46% (cheaper than usual) | #3753 of 5317 (1 = cheapest) |
| PE | 32.61 | 28.18 | 44.51 | 41% (cheaper than usual) | #2188 of 2973 (1 = cheapest) |
| PS | 1.24 | 1.16 | 1.27 | 54% (pricier than usual) | #1856 of 5146 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on UTI.